Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 39 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Peptide Fragments  [Clear All Filters]
2020
Arvanitaki, A., Mouratoglou S. Anastasia, Evangeliou A., Grosomanidis V., Hadjimiltiades S., Skoura L., et al. (2020).  Quality of Life is Related to Haemodynamics in Precapillary Pulmonary Hypertension.. Heart Lung Circ. 29(1), 142-148.
2019
Lim, B., Tsolaki M., Soosaipillai A., Brown M., Zilakaki M., Tagaraki F., et al. (2019).  Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer's disease.. Clin Chem Lab Med. 57(12), 1875-1881.
2017
Nathan, P. J., Lim Y. Ying, Abbott R., Galluzzi S., Marizzoni M., Babiloni C., et al. (2017).  Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI).. Neurobiol Aging. 53, 1-10.
Paraskevas, G. P., Kasselimis D., Kourtidou E., Constantinides V., Bougea A., Potagas C., et al. (2017).  Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia.. J Alzheimers Dis. 55(4), 1453-1461.
Constantinides, V. C., Paraskevas G. P., Emmanouilidou E., Petropoulou O., Bougea A., Vekrellis K., et al. (2017).  CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes.. J Neurol Sci. 382, 91-95.
Kesidou, E., Touloumi O., Lagoudaki R., Nousiopoulou E., Theotokis P., Poulatsidou K-N., et al. (2017).  Humoral response in experimental autoimmune encephalomyelitis targets neural precursor cells in the central nervous system of naive rodents.. J Neuroinflammation. 14(1), 227.
Bosco, P., Redolfi A., Bocchetta M., Ferrari C., Mega A., Galluzzi S., et al. (2017).  The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study.. Alzheimers Dement. 13(9), 1013-1023.
van Doorn, L. J. C. van Wa, Gispert J. D., H Kuiperij B., Claassen J. A. H. R., Arighi A., Baldeiras I., et al. (2017).  Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.. J Alzheimers Dis. 56(2), 543-555.
Reijs, B. L. R., Ramakers I. H. G. B., Köhler S., Teunissen C. E., Koel-Simmelink M., Nathan P. J., et al. (2017).  Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.. J Alzheimers Dis. 60(3), 1119-1128.
Reijs, B. L. R., Ramakers I. H. G. B., Elias-Sonnenschein L., Teunissen C. E., Koel-Simmelink M., Tsolaki M., et al. (2017).  Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.. J Alzheimers Dis. 60(3), 1025-1034.
2016
Galluzzi, S., Marizzoni M., Babiloni C., Albani D., Antelmi L., Bagnoli C., et al. (2016).  Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.. J Intern Med. 279(6), 576-91.
Meulenbroek, O., O'Dwyer S., de Jong D., van Spijker G., Kennelly S., Cregg F., et al. (2016).  European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flo. BMJ Open. 6(7), e011584.
Theotokis, P., Touloumi O., Lagoudaki R., Nousiopoulou E., Kesidou E., Siafis S., et al. (2016).  Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.. J Neuroinflammation. 13(1), 265.
2015
Anastasilakis, A. D., Polyzos S. A., Efstathiadou Z. A., Savvidis M., Sakellariou G. T., Papatheodorou A., et al. (2015).  Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.. Metabolism. 64(10), 1291-7.
2014
Tanaka, K., Shimizu T., Yanagita T., Nemoto T., Nakamura K., Taniuchi K., et al. (2014).  Brain RVD-haemopressin, a haemoglobin-derived peptide, inhibits bombesin-induced central activation of adrenomedullary outflow in the rat.. Br J Pharmacol. 171(1), 202-13.
Karatzoglou, I., Yavropoulou M. P., Pikilidou M., Germanidis G., Akriviadis E., Papazisi A., et al. (2014).  Postprandial response of bone turnover markers in patients with Crohn's disease.. World J Gastroenterol. 20(28), 9534-40.
Vlachos, S., Tsaroucha A. K., Konstantoudakis G., Papachristou F., Trypsianis G., Schizas D., et al. (2014).  Serum profiles of M30, M65 and interleukin-17 compared with C-reactive protein in patients with mild and severe acute pancreatitis.. J Hepatobiliary Pancreat Sci. 21(12), 911-8.
2013
Giannakopoulou, A., Grigoriadis N., Bekiari C., Lourbopoulos A., Dori I., Tsingotjidou A. S., et al. (2013).  Acute inflammation alters adult hippocampal neurogenesis in a multiple sclerosis mouse model.. J Neurosci Res. 91(7), 890-900.
Anastasilakis, A. D., Polyzos S. A., Gkiomisi A., Bisbinas I., Gerou S., & Makras P. (2013).  Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.. J Clin Endocrinol Metab. 98(8), 3206-12.
Dimitroulas, T., Douglas K. M. J., Panoulas V. F., Toms T., Smith J. P., Treharne G. J., et al. (2013).  Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors.. Clin Rheumatol. 32(9), 1357-64.
Farahmand, P., Marín F., Hawkins F., Möricke R., Ringe J. D., Glüer C-C., et al. (2013).  Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis.. Osteoporos Int. 24(12), 2971-81.
Clerx, L., van Rossum I. A., Burns L., Knol D. L., Scheltens P., Verhey F., et al. (2013).  Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment.. Neurobiol Aging. 34(8), 2003-13.
Vos, S. J. B., van Rossum I. A., Verhey F., Knol D. L., Soininen H., Wahlund L-O., et al. (2013).  Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.. Neurology. 80(12), 1124-32.
2012
Vos, S., van Rossum I., Burns L., Knol D., Scheltens P., Soininen H., et al. (2012).  Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.. Neurobiol Aging. 33(10), 2272-81.
2011
Speletas, M., Argentou N., Karanikas V., Gramoustianou E. S., Mandala E., Braimi M., et al. (2011).  Survivin isoform expression patterns in CML patients correlate with resistance to imatinib and progression, but do not trigger cytolytic responses.. Clin Immunol. 139(2), 155-63.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές